drugset / Trial / NCT07450521
Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males
RandomizedParallel-groupQuadruple-blindOther
Summary
A randomized, double-blind, placebo-controlled, study to assess the safety, tolerability, and PK of MTX-463 when administered via SC injection in healthy adult males.
Timeline
- Start
- 2026-02-18
- Primary completion
- 2026-03-11
- Completion
- 2026-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MTX-463 | Monoclonal antibody | 250 mg | Subcutaneous |
Indications
No indication recorded.